GleamWall
中文EN

SNWV SANUWAVE Health, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1417663 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.1%
TTM net income YoY128.0%
TTM EPS YoY76.9%
Revenue 3-yr CAGR29.5%
Net income 3-yr CAGR—

Margins

Gross margin76.0%
Operating margin-4.5%
Net margin6.3%
FCF margin6.3%
EBITDA margin-1.7%

Returns

ROE—
ROA7.6%
ROIC (approx.)-124.0%
Asset turnover1.20x

Leverage & solvency

Liabilities / assets91.2%
Debt / equity0.00x
Current ratio1.18x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.28x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue1.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$8.58M$9.74M$9.62M$13.09M$11.27M$10.05M$9.33M$10.33M
Cost of revenue$1.95M$2.31M$2.19M$3.39M$2.53M$2.21M$1.96M$2.29M
Gross profit$6.63M$7.42M$7.43M$9.70M$8.74M$7.85M$7.38M$8.04M
R&D expense$426,000$628,000$660,000$606,000$345,000$194,000$208,000$154,000
SG&A expense$5.13M$4.90M$5.25M$6.06M$5.19M$4.37M$4.84M$3.80M
Operating income-$1.07M-$280,000-$1.12M$615,000$903,000$1.44M$601,000$2.01M
Interest expense$276,000$518,000$546,000—$1.79M$1.94M$1.91M$2.52M
Income tax$63,000$6,000—$86,000$0$0——
Net income-$1.42M-$682,000-$1.44M$6.11M$9.69M$551,000-$6.12M-$13.31M
EBITDA-$798,000-$29,000-$830,000$955,000$1.12M$1.61M$810,000$2.23M
EPS (basic)-0.16-0.08-0.17—1.130.06-0.72—
EPS (diluted)-0.16-0.08-0.17—0.39-0.04-0.72—
Weighted avg. shares (diluted)8.60M8.60M8.59M—9.14M9.17M8.55M—
Balance sheet
Cash & equivalents$6.57M$9.38M$10.78M$11.96M$9.60M$8.50M$8.50M$10.24M
Receivables$4.96M$5.80M$6.00M$5.42M$4.62M$3.85M$3.87M$3.33M
Inventory$6.72M$7.07M$5.90M$5.93M$6.81M$5.91M$5.46M$4.15M
Current assets$19.30M$23.20M$23.96M$24.63M$22.63M$20.17M$18.83M$18.40M
PP&E, net$2.35M$2.25M$1.91M$1.97M$1.99M$1.59M$449,000$303,000
Goodwill$7.26M$7.26M$7.26M$7.26M$7.26M$7.26M$7.26M$7.26M
Intangibles$2.70M$2.89M$2.92M$3.03M$3.20M$3.38M$3.55M$3.73M
Total assets$32.52M$36.60M$37.10M$37.34M$35.60M$33.05M$30.86M$30.12M
Current liabilities$16.39M$18.17M$18.30M$17.85M$23.98M$50.42M$50.78M$45.42M
Short-term debt——$5.75M$5.75M$5.75M———
Long-term debt——$14.76M$16.14M$17.53M———
Total debt——$20.51M$21.89M$23.28M———
Total liabilities$29.67M$33.82M$35.26M$35.72M$43.19M$51.84M$51.67M$45.91M
Shareholders' equity$2.85M$2.79M$1.84M$1.62M-$7.59M-$18.80M-$20.81M-$15.79M
Net debt——$9.73M$9.93M$13.68M———
Shares outstanding8.60M8.60M8.59M8.59M8.58M8.57M8.55M8.54M
Cash flow statement
Operating cash flow-$851,000$425,000$397,000$3.32M$1.08M$993,000-$1.52M$741,000
Capital expenditure$236,000$334,000$23,000$96,000$525,000$1.16M$162,000$236,000
Free cash flow-$1.09M$91,000$374,000$3.22M$556,000-$166,000-$1.68M$505,000
Investing cash flow-$205,000-$448,000-$158,000$279,000$4.47M-$1.16M-$162,000-$236,000
Financing cash flow-$1.75M-$1.38M-$1.42M-$1.24M-$4.45M$161,000-$57,000$6.47M
Depreciation & amortization$274,000$251,000$294,000$340,000$222,000$174,000$209,000$218,000
Stock-based compensation$1.48M$1.57M$1.61M$1.34M$1.40M$1.13M$975,000$1.51M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.